| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vision Screening | 5 | 2023 | 40 | 1.880 |
Why?
|
| Amblyopia | 4 | 2023 | 43 | 1.780 |
Why?
|
| Refractive Errors | 3 | 2023 | 24 | 1.680 |
Why?
|
| Lupus Nephritis | 6 | 2021 | 193 | 1.310 |
Why?
|
| Refraction, Ocular | 4 | 2020 | 61 | 1.100 |
Why?
|
| Histamine H2 Antagonists | 2 | 2021 | 45 | 0.970 |
Why?
|
| Lenses, Intraocular | 2 | 2022 | 96 | 0.940 |
Why?
|
| Proton Pump Inhibitors | 2 | 2021 | 91 | 0.910 |
Why?
|
| Anisometropia | 1 | 2023 | 12 | 0.860 |
Why?
|
| Hyperopia | 1 | 2023 | 14 | 0.860 |
Why?
|
| Astigmatism | 1 | 2023 | 17 | 0.850 |
Why?
|
| Ectopia Lentis | 1 | 2022 | 4 | 0.840 |
Why?
|
| Aphakia | 1 | 2022 | 7 | 0.830 |
Why?
|
| Aphakia, Postcataract | 1 | 2022 | 36 | 0.810 |
Why?
|
| Causality | 1 | 2022 | 82 | 0.810 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2022 | 627 | 0.770 |
Why?
|
| Humans | 91 | 2023 | 68618 | 0.760 |
Why?
|
| Models, Biological | 2 | 2016 | 981 | 0.670 |
Why?
|
| Complement Factor H | 1 | 2019 | 21 | 0.650 |
Why?
|
| Retrospective Studies | 31 | 2023 | 7277 | 0.620 |
Why?
|
| Macular Degeneration | 1 | 2019 | 75 | 0.610 |
Why?
|
| Complement Activation | 1 | 2019 | 145 | 0.600 |
Why?
|
| Pain, Postoperative | 6 | 2022 | 214 | 0.580 |
Why?
|
| Arthroplasty, Replacement, Hip | 4 | 2022 | 130 | 0.560 |
Why?
|
| Female | 57 | 2023 | 38074 | 0.550 |
Why?
|
| Analgesia, Epidural | 4 | 2018 | 40 | 0.540 |
Why?
|
| Child | 16 | 2023 | 6405 | 0.530 |
Why?
|
| Autonomic Nerve Block | 3 | 2023 | 15 | 0.510 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2022 | 756 | 0.510 |
Why?
|
| Analgesia | 3 | 2022 | 58 | 0.480 |
Why?
|
| Visual Acuity | 3 | 2022 | 236 | 0.470 |
Why?
|
| Prospective Studies | 12 | 2023 | 3705 | 0.460 |
Why?
|
| Anesthesia | 3 | 2022 | 120 | 0.460 |
Why?
|
| Algorithms | 5 | 2022 | 1196 | 0.450 |
Why?
|
| Biomarkers | 6 | 2021 | 1593 | 0.440 |
Why?
|
| Computer Simulation | 5 | 2022 | 706 | 0.430 |
Why?
|
| Peroxiredoxins | 1 | 2012 | 34 | 0.430 |
Why?
|
| Epistasis, Genetic | 1 | 2012 | 32 | 0.430 |
Why?
|
| Free Tissue Flaps | 3 | 2020 | 67 | 0.420 |
Why?
|
| Male | 43 | 2023 | 37321 | 0.420 |
Why?
|
| Neuraminidase | 3 | 2021 | 36 | 0.420 |
Why?
|
| Postoperative Complications | 5 | 2022 | 1615 | 0.400 |
Why?
|
| Smoking | 2 | 2022 | 1452 | 0.390 |
Why?
|
| Cleft Palate | 2 | 2022 | 34 | 0.390 |
Why?
|
| Cleft Lip | 2 | 2022 | 33 | 0.390 |
Why?
|
| Analgesics, Opioid | 4 | 2022 | 498 | 0.390 |
Why?
|
| Endocrine Disruptors | 3 | 2022 | 31 | 0.390 |
Why?
|
| Lens Implantation, Intraocular | 3 | 2022 | 152 | 0.380 |
Why?
|
| Incidence | 5 | 2022 | 1603 | 0.380 |
Why?
|
| Mesangial Cells | 2 | 2021 | 37 | 0.370 |
Why?
|
| Adult | 29 | 2022 | 21403 | 0.370 |
Why?
|
| Kidney | 5 | 2021 | 945 | 0.370 |
Why?
|
| Software | 3 | 2022 | 418 | 0.360 |
Why?
|
| Adolescent | 14 | 2023 | 8912 | 0.360 |
Why?
|
| Breast Neoplasms | 3 | 2017 | 1536 | 0.340 |
Why?
|
| Regression Analysis | 2 | 2014 | 737 | 0.340 |
Why?
|
| Cytokines | 4 | 2021 | 866 | 0.330 |
Why?
|
| Cataract | 2 | 2020 | 134 | 0.320 |
Why?
|
| Acetaminophen | 2 | 2019 | 111 | 0.310 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 1851 | 0.310 |
Why?
|
| Age Factors | 4 | 2021 | 1864 | 0.300 |
Why?
|
| Hypothermia | 2 | 2018 | 37 | 0.300 |
Why?
|
| Alkanesulfonic Acids | 2 | 2019 | 54 | 0.300 |
Why?
|
| Head and Neck Neoplasms | 3 | 2020 | 561 | 0.300 |
Why?
|
| Preoperative Care | 2 | 2019 | 275 | 0.290 |
Why?
|
| Skin | 2 | 2021 | 451 | 0.290 |
Why?
|
| Environmental Exposure | 3 | 2020 | 269 | 0.290 |
Why?
|
| Fluorocarbons | 2 | 2019 | 82 | 0.290 |
Why?
|
| ROC Curve | 4 | 2021 | 392 | 0.290 |
Why?
|
| Analgesia, Obstetrical | 2 | 2018 | 15 | 0.270 |
Why?
|
| Nerve Block | 2 | 2017 | 55 | 0.270 |
Why?
|
| Water Pollutants, Chemical | 3 | 2019 | 328 | 0.260 |
Why?
|
| Aged | 19 | 2020 | 14862 | 0.260 |
Why?
|
| Predictive Value of Tests | 6 | 2019 | 1465 | 0.250 |
Why?
|
| Risk Factors | 10 | 2022 | 5731 | 0.250 |
Why?
|
| Middle Aged | 25 | 2020 | 21147 | 0.240 |
Why?
|
| South Carolina | 7 | 2020 | 2752 | 0.240 |
Why?
|
| Treatment Outcome | 13 | 2020 | 7029 | 0.240 |
Why?
|
| Anesthesia, General | 3 | 2021 | 86 | 0.240 |
Why?
|
| Child, Preschool | 6 | 2022 | 3187 | 0.240 |
Why?
|
| Anesthetics, Local | 3 | 2022 | 83 | 0.230 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 240 | 0.230 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 3259 | 0.230 |
Why?
|
| Education, Dental | 2 | 2015 | 63 | 0.230 |
Why?
|
| Case-Control Studies | 4 | 2022 | 1553 | 0.220 |
Why?
|
| Equipment Design | 3 | 2020 | 500 | 0.220 |
Why?
|
| Smoking Cessation | 2 | 2022 | 1034 | 0.220 |
Why?
|
| Electroencephalography | 2 | 2018 | 418 | 0.220 |
Why?
|
| Stellate Ganglion | 1 | 2023 | 9 | 0.220 |
Why?
|
| Computational Biology | 3 | 2022 | 190 | 0.220 |
Why?
|
| Intraoperative Complications | 3 | 2018 | 129 | 0.210 |
Why?
|
| Sensitivity and Specificity | 3 | 2023 | 1753 | 0.210 |
Why?
|
| Body Temperature | 2 | 2020 | 116 | 0.210 |
Why?
|
| Receptors, Nicotinic | 1 | 2022 | 41 | 0.210 |
Why?
|
| Educational Measurement | 2 | 2015 | 254 | 0.200 |
Why?
|
| Medicaid | 2 | 2023 | 302 | 0.200 |
Why?
|
| Tool Use Behavior | 1 | 2021 | 4 | 0.200 |
Why?
|
| Laryngeal Masks | 1 | 2021 | 9 | 0.200 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2022 | 63 | 0.200 |
Why?
|
| Phthalic Acids | 2 | 2020 | 28 | 0.190 |
Why?
|
| Propofol | 1 | 2021 | 36 | 0.190 |
Why?
|
| Anesthesia, Spinal | 2 | 2019 | 16 | 0.190 |
Why?
|
| Young Adult | 7 | 2022 | 5717 | 0.190 |
Why?
|
| Triage | 1 | 2022 | 109 | 0.190 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2021 | 14 | 0.190 |
Why?
|
| Spinal Cord Stimulation | 1 | 2021 | 14 | 0.190 |
Why?
|
| Pain Measurement | 5 | 2022 | 328 | 0.190 |
Why?
|
| Myotomy | 1 | 2020 | 14 | 0.190 |
Why?
|
| Saliva | 1 | 2021 | 142 | 0.190 |
Why?
|
| Coronary Vessels | 2 | 2013 | 313 | 0.180 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2020 | 24 | 0.180 |
Why?
|
| Drug Discovery | 1 | 2021 | 94 | 0.180 |
Why?
|
| Clinical Competence | 2 | 2018 | 657 | 0.180 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 191 | 0.180 |
Why?
|
| Biological Products | 1 | 2021 | 78 | 0.180 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 115 | 0.180 |
Why?
|
| Chronic Pain | 1 | 2022 | 110 | 0.180 |
Why?
|
| Linear Models | 3 | 2019 | 521 | 0.180 |
Why?
|
| Marijuana Smoking | 1 | 2021 | 108 | 0.180 |
Why?
|
| Bacteria | 1 | 2021 | 193 | 0.180 |
Why?
|
| Hypohidrosis | 1 | 2020 | 5 | 0.180 |
Why?
|
| Flushing | 1 | 2020 | 7 | 0.180 |
Why?
|
| Pregnancy Trimesters | 1 | 2020 | 14 | 0.180 |
Why?
|
| Genomics | 2 | 2022 | 168 | 0.180 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 114 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 191 | 0.180 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2020 | 14 | 0.180 |
Why?
|
| Esophageal Achalasia | 1 | 2020 | 78 | 0.180 |
Why?
|
| Betacoronavirus | 1 | 2021 | 116 | 0.180 |
Why?
|
| Phacoemulsification | 1 | 2020 | 69 | 0.180 |
Why?
|
| Autoantibodies | 2 | 2021 | 434 | 0.180 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 175 | 0.170 |
Why?
|
| Maternal Exposure | 1 | 2020 | 75 | 0.170 |
Why?
|
| Respiratory Rate | 1 | 2019 | 7 | 0.170 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 16 | 0.170 |
Why?
|
| Glycosphingolipids | 1 | 2020 | 51 | 0.170 |
Why?
|
| Breakthrough Pain | 1 | 2019 | 3 | 0.170 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2019 | 32 | 0.170 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2019 | 15 | 0.170 |
Why?
|
| Spectrin | 1 | 2019 | 17 | 0.170 |
Why?
|
| Genotype | 2 | 2022 | 786 | 0.170 |
Why?
|
| Strabismus | 1 | 2019 | 37 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2021 | 211 | 0.170 |
Why?
|
| Sex Factors | 2 | 2021 | 1266 | 0.170 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2019 | 24 | 0.170 |
Why?
|
| Tobacco Products | 1 | 2022 | 234 | 0.170 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 711 | 0.170 |
Why?
|
| Logistic Models | 3 | 2019 | 1420 | 0.170 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2019 | 250 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 146 | 0.170 |
Why?
|
| Axial Length, Eye | 1 | 2019 | 15 | 0.170 |
Why?
|
| Complement C3a | 1 | 2019 | 3 | 0.170 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 92 | 0.170 |
Why?
|
| Cholecalciferol | 1 | 2020 | 143 | 0.170 |
Why?
|
| Complement Factor B | 1 | 2019 | 19 | 0.170 |
Why?
|
| Complement C5a | 1 | 2019 | 15 | 0.160 |
Why?
|
| Scleroderma, Diffuse | 1 | 2019 | 25 | 0.160 |
Why?
|
| Seafood | 1 | 2019 | 17 | 0.160 |
Why?
|
| Cesarean Section | 1 | 2019 | 101 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1293 | 0.160 |
Why?
|
| Schools | 1 | 2020 | 156 | 0.160 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 45 | 0.160 |
Why?
|
| Multivariate Analysis | 4 | 2019 | 1046 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 2 | 2016 | 1026 | 0.160 |
Why?
|
| Liver Failure, Acute | 1 | 2019 | 49 | 0.160 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2019 | 43 | 0.160 |
Why?
|
| Anesthetists | 1 | 2018 | 5 | 0.160 |
Why?
|
| Brachial Plexus Block | 1 | 2018 | 5 | 0.160 |
Why?
|
| Neuromuscular Blockade | 1 | 2018 | 9 | 0.160 |
Why?
|
| Masks | 1 | 2018 | 10 | 0.160 |
Why?
|
| Cardiologists | 1 | 2018 | 9 | 0.160 |
Why?
|
| Pregnancy | 6 | 2020 | 2334 | 0.160 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2019 | 100 | 0.160 |
Why?
|
| Biological Assay | 1 | 2019 | 88 | 0.160 |
Why?
|
| Positive-Pressure Respiration | 1 | 2018 | 27 | 0.160 |
Why?
|
| Intraoperative Care | 2 | 2018 | 91 | 0.160 |
Why?
|
| Dental Bonding | 2 | 2015 | 39 | 0.160 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2018 | 25 | 0.160 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 61 | 0.150 |
Why?
|
| Conscious Sedation | 2 | 2022 | 61 | 0.150 |
Why?
|
| Educational Technology | 2 | 2015 | 22 | 0.150 |
Why?
|
| Computer-Aided Design | 2 | 2015 | 101 | 0.150 |
Why?
|
| Cataract Extraction | 1 | 2019 | 127 | 0.150 |
Why?
|
| Labor, Obstetric | 1 | 2018 | 23 | 0.150 |
Why?
|
| Macrophages | 1 | 2021 | 647 | 0.150 |
Why?
|
| Estradiol | 1 | 2019 | 176 | 0.150 |
Why?
|
| Crowns | 2 | 2015 | 34 | 0.150 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 4848 | 0.150 |
Why?
|
| Needles | 1 | 2018 | 34 | 0.150 |
Why?
|
| Forecasting | 1 | 2019 | 277 | 0.150 |
Why?
|
| Pancreatectomy | 1 | 2019 | 129 | 0.150 |
Why?
|
| Bupivacaine | 1 | 2018 | 27 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 219 | 0.150 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2019 | 101 | 0.150 |
Why?
|
| Scleroderma, Systemic | 1 | 2021 | 446 | 0.150 |
Why?
|
| Mucin-1 | 1 | 2017 | 35 | 0.150 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2019 | 105 | 0.150 |
Why?
|
| Dexamethasone | 1 | 2018 | 150 | 0.150 |
Why?
|
| Anesthesiologists | 1 | 2018 | 30 | 0.150 |
Why?
|
| Podocytes | 1 | 2019 | 113 | 0.150 |
Why?
|
| Environmental Monitoring | 1 | 2019 | 180 | 0.150 |
Why?
|
| Machine Learning | 1 | 2019 | 170 | 0.150 |
Why?
|
| Dietary Supplements | 1 | 2020 | 332 | 0.150 |
Why?
|
| Immunoglobulins | 1 | 2017 | 97 | 0.150 |
Why?
|
| Cohort Studies | 6 | 2020 | 2358 | 0.150 |
Why?
|
| Genetic Research | 1 | 2017 | 16 | 0.140 |
Why?
|
| Thoracotomy | 1 | 2017 | 25 | 0.140 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 177 | 0.140 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2018 | 147 | 0.140 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 124 | 0.140 |
Why?
|
| Pancreatitis, Chronic | 1 | 2019 | 168 | 0.140 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 2279 | 0.140 |
Why?
|
| Receptors, IgG | 1 | 2017 | 94 | 0.140 |
Why?
|
| Linezolid | 1 | 2016 | 7 | 0.140 |
Why?
|
| Fibroblasts | 1 | 2021 | 902 | 0.140 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2016 | 7 | 0.140 |
Why?
|
| Bottle-Nosed Dolphin | 1 | 2017 | 86 | 0.140 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 180 | 0.140 |
Why?
|
| Partial Thromboplastin Time | 1 | 2016 | 57 | 0.140 |
Why?
|
| Gene Expression | 1 | 2019 | 770 | 0.140 |
Why?
|
| Early Goal-Directed Therapy | 1 | 2016 | 6 | 0.130 |
Why?
|
| Vancomycin | 1 | 2016 | 60 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2015 | 333 | 0.130 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2018 | 146 | 0.130 |
Why?
|
| Echocardiography | 1 | 2019 | 515 | 0.130 |
Why?
|
| Plasminogen Activator Inhibitor 2 | 1 | 2015 | 3 | 0.130 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 90 | 0.130 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2015 | 24 | 0.130 |
Why?
|
| Dentistry, Operative | 1 | 2015 | 5 | 0.130 |
Why?
|
| Self-Evaluation Programs | 1 | 2015 | 6 | 0.130 |
Why?
|
| Shock, Septic | 1 | 2015 | 101 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2016 | 92 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2021 | 447 | 0.130 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 397 | 0.130 |
Why?
|
| Orthodontic Brackets | 1 | 2015 | 4 | 0.130 |
Why?
|
| Cortical Bone | 1 | 2015 | 2 | 0.130 |
Why?
|
| Curing Lights, Dental | 1 | 2015 | 3 | 0.130 |
Why?
|
| Heparin | 1 | 2016 | 205 | 0.130 |
Why?
|
| Dental Cements | 1 | 2015 | 10 | 0.130 |
Why?
|
| Angioedemas, Hereditary | 1 | 2015 | 26 | 0.130 |
Why?
|
| Orthodontics, Corrective | 1 | 2015 | 9 | 0.130 |
Why?
|
| Plasma Substitutes | 1 | 2015 | 15 | 0.130 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 2015 | 24 | 0.130 |
Why?
|
| Iodides | 1 | 2015 | 15 | 0.130 |
Why?
|
| Dental Prosthesis Design | 1 | 2015 | 37 | 0.120 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 221 | 0.120 |
Why?
|
| Acrylic Resins | 1 | 2015 | 48 | 0.120 |
Why?
|
| Lumbosacral Plexus | 3 | 2022 | 15 | 0.120 |
Why?
|
| Albumins | 1 | 2015 | 72 | 0.120 |
Why?
|
| Bias | 1 | 2015 | 148 | 0.120 |
Why?
|
| Mandible | 1 | 2015 | 53 | 0.120 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2015 | 52 | 0.120 |
Why?
|
| Fluid Therapy | 1 | 2015 | 59 | 0.120 |
Why?
|
| Maxilla | 1 | 2015 | 63 | 0.120 |
Why?
|
| Random Allocation | 1 | 2015 | 442 | 0.120 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2014 | 93 | 0.120 |
Why?
|
| Epilepsy | 1 | 2018 | 336 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2016 | 652 | 0.120 |
Why?
|
| Tracheotomy | 1 | 2014 | 17 | 0.120 |
Why?
|
| Animals | 9 | 2022 | 20881 | 0.110 |
Why?
|
| Cell Line | 4 | 2021 | 1752 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 504 | 0.110 |
Why?
|
| Hypertension | 1 | 2023 | 1535 | 0.110 |
Why?
|
| Copper | 1 | 2015 | 149 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2016 | 356 | 0.110 |
Why?
|
| Vitamin D | 2 | 2020 | 516 | 0.110 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 597 | 0.110 |
Why?
|
| Tooth Preparation | 1 | 2013 | 7 | 0.110 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 159 | 0.110 |
Why?
|
| Blood Flow Velocity | 1 | 2013 | 172 | 0.110 |
Why?
|
| Ablation Techniques | 1 | 2013 | 33 | 0.110 |
Why?
|
| Coronary Circulation | 1 | 2013 | 136 | 0.110 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 57 | 0.110 |
Why?
|
| Infant | 5 | 2020 | 2891 | 0.100 |
Why?
|
| Ultrasonography, Mammary | 1 | 2012 | 39 | 0.100 |
Why?
|
| Critical Illness | 1 | 2014 | 191 | 0.100 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2012 | 62 | 0.100 |
Why?
|
| Obesity | 2 | 2023 | 1076 | 0.100 |
Why?
|
| Models, Genetic | 1 | 2012 | 161 | 0.100 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2013 | 116 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 232 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 142 | 0.100 |
Why?
|
| Receptor, ErbB-2 | 1 | 2012 | 129 | 0.100 |
Why?
|
| Glottis | 1 | 2011 | 17 | 0.100 |
Why?
|
| Laryngomalacia | 1 | 2011 | 12 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2015 | 400 | 0.100 |
Why?
|
| Lipids | 1 | 2013 | 298 | 0.100 |
Why?
|
| Education, Medical | 1 | 2013 | 147 | 0.100 |
Why?
|
| United States | 6 | 2023 | 7367 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 369 | 0.100 |
Why?
|
| Mice | 5 | 2021 | 8474 | 0.090 |
Why?
|
| Brain | 1 | 2021 | 2176 | 0.090 |
Why?
|
| Time Factors | 5 | 2018 | 4655 | 0.090 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2012 | 138 | 0.090 |
Why?
|
| Dental Care for Disabled | 1 | 2010 | 8 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2673 | 0.090 |
Why?
|
| Proteinuria | 2 | 2021 | 136 | 0.090 |
Why?
|
| Mice, Inbred MRL lpr | 2 | 2021 | 118 | 0.090 |
Why?
|
| Seizures | 1 | 2012 | 279 | 0.090 |
Why?
|
| Hospitalization | 3 | 2022 | 978 | 0.090 |
Why?
|
| Attitude to Health | 2 | 2010 | 403 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 2077 | 0.090 |
Why?
|
| Periodontal Diseases | 1 | 2010 | 54 | 0.090 |
Why?
|
| Mitochondria | 1 | 2014 | 643 | 0.090 |
Why?
|
| Plasticizers | 2 | 2020 | 5 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 786 | 0.080 |
Why?
|
| Oral Health | 1 | 2009 | 49 | 0.080 |
Why?
|
| Nicotine | 2 | 2022 | 350 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2019 | 2007 | 0.080 |
Why?
|
| Plasma | 2 | 2019 | 58 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2013 | 1451 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 696 | 0.070 |
Why?
|
| Ethanol | 1 | 2013 | 893 | 0.070 |
Why?
|
| Prevalence | 3 | 2017 | 1619 | 0.070 |
Why?
|
| Observer Variation | 2 | 2018 | 330 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 507 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2010 | 581 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 1745 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 2791 | 0.060 |
Why?
|
| Faculty, Dental | 2 | 2015 | 22 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2550 | 0.060 |
Why?
|
| Spinal Cord Injuries | 1 | 2010 | 551 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 767 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 694 | 0.060 |
Why?
|
| Essential Hypertension | 1 | 2023 | 2 | 0.060 |
Why?
|
| Delaware | 1 | 2023 | 4 | 0.060 |
Why?
|
| Critical Pathways | 1 | 2023 | 33 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2020 | 1738 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2014 | 216 | 0.050 |
Why?
|
| Asia | 1 | 2022 | 59 | 0.050 |
Why?
|
| El Salvador | 1 | 2022 | 8 | 0.050 |
Why?
|
| Intensive Care Units | 2 | 2016 | 344 | 0.050 |
Why?
|
| Umbilical Cord | 1 | 2022 | 19 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2015 | 880 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2A6 | 1 | 2022 | 5 | 0.050 |
Why?
|
| Volunteers | 1 | 2022 | 30 | 0.050 |
Why?
|
| Prognosis | 2 | 2019 | 2093 | 0.050 |
Why?
|
| Epigenomics | 1 | 2022 | 29 | 0.050 |
Why?
|
| Bupropion | 1 | 2022 | 63 | 0.050 |
Why?
|
| Transcription Factor AP-2 | 1 | 2021 | 9 | 0.050 |
Why?
|
| Symptom Flare Up | 1 | 2021 | 20 | 0.050 |
Why?
|
| Databases, Chemical | 1 | 2021 | 3 | 0.050 |
Why?
|
| Gastrointestinal Contents | 1 | 2022 | 13 | 0.050 |
Why?
|
| Environmental Health | 1 | 2022 | 23 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2021 | 29 | 0.050 |
Why?
|
| Length of Stay | 2 | 2016 | 780 | 0.050 |
Why?
|
| DNA, Ribosomal | 1 | 2021 | 59 | 0.050 |
Why?
|
| Documentation | 1 | 2022 | 83 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 85 | 0.050 |
Why?
|
| Databases, Protein | 1 | 2021 | 49 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 124 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2021 | 62 | 0.050 |
Why?
|
| Demography | 1 | 2022 | 279 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2022 | 220 | 0.050 |
Why?
|
| Laboratories | 1 | 2021 | 44 | 0.050 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 150 | 0.050 |
Why?
|
| Serum | 1 | 2021 | 24 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 208 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2023 | 239 | 0.050 |
Why?
|
| Tonometry, Ocular | 1 | 2020 | 11 | 0.050 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2020 | 3 | 0.050 |
Why?
|
| Dibutyl Phthalate | 1 | 2020 | 5 | 0.050 |
Why?
|
| Phylogeny | 1 | 2021 | 197 | 0.050 |
Why?
|
| Cyclohexanes | 1 | 2020 | 10 | 0.050 |
Why?
|
| Esters | 1 | 2020 | 22 | 0.050 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2020 | 22 | 0.050 |
Why?
|
| Dicarboxylic Acids | 1 | 2020 | 16 | 0.050 |
Why?
|
| Aftercare | 1 | 2021 | 114 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 284 | 0.050 |
Why?
|
| Health Care Costs | 2 | 2016 | 346 | 0.050 |
Why?
|
| Electrodes, Implanted | 1 | 2021 | 98 | 0.050 |
Why?
|
| Ligands | 1 | 2021 | 317 | 0.050 |
Why?
|
| Phosphorous Acids | 1 | 2020 | 4 | 0.040 |
Why?
|
| Oseltamivir | 1 | 2020 | 6 | 0.040 |
Why?
|
| G(M3) Ganglioside | 1 | 2020 | 7 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 120 | 0.040 |
Why?
|
| Insurance, Dental | 2 | 2010 | 11 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2021 | 171 | 0.040 |
Why?
|
| Leg | 1 | 2021 | 191 | 0.040 |
Why?
|
| Lactosylceramides | 1 | 2020 | 27 | 0.040 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2020 | 60 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2020 | 143 | 0.040 |
Why?
|
| Transcriptome | 1 | 2021 | 164 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 139 | 0.040 |
Why?
|
| Myocardium | 2 | 2019 | 1204 | 0.040 |
Why?
|
| Sunlight | 1 | 2020 | 59 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2020 | 131 | 0.040 |
Why?
|
| Face | 1 | 2020 | 46 | 0.040 |
Why?
|
| Instillation, Drug | 1 | 2019 | 15 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2014 | 867 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 247 | 0.040 |
Why?
|
| Ophthalmic Solutions | 1 | 2019 | 39 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2021 | 244 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 384 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2022 | 453 | 0.040 |
Why?
|
| Ketorolac | 1 | 2019 | 11 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2020 | 114 | 0.040 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2019 | 40 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2019 | 89 | 0.040 |
Why?
|
| Reoperation | 1 | 2021 | 467 | 0.040 |
Why?
|
| Educational Status | 2 | 2010 | 273 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 249 | 0.040 |
Why?
|
| Income | 2 | 2010 | 167 | 0.040 |
Why?
|
| Luciferases | 1 | 2019 | 105 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 455 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2019 | 46 | 0.040 |
Why?
|
| Neurologists | 1 | 2018 | 15 | 0.040 |
Why?
|
| Hospitals, Private | 1 | 2018 | 15 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 792 | 0.040 |
Why?
|
| Employment | 2 | 2010 | 154 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2021 | 266 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 191 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 145 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 88 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2021 | 586 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2019 | 238 | 0.040 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2018 | 17 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 238 | 0.040 |
Why?
|
| Progesterone | 1 | 2019 | 115 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 411 | 0.040 |
Why?
|
| Fishes | 1 | 2018 | 77 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2018 | 70 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2018 | 18 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2018 | 112 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2019 | 100 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 850 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2018 | 75 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2022 | 413 | 0.040 |
Why?
|
| Immunologic Surveillance | 1 | 2017 | 10 | 0.040 |
Why?
|
| Brazil | 1 | 2017 | 48 | 0.040 |
Why?
|
| Coronary Angiography | 2 | 2013 | 866 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2018 | 95 | 0.040 |
Why?
|
| Japan | 1 | 2017 | 68 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 536 | 0.040 |
Why?
|
| Physician's Role | 1 | 2018 | 116 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 214 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2017 | 93 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2018 | 239 | 0.040 |
Why?
|
| Early Ambulation | 1 | 2017 | 8 | 0.040 |
Why?
|
| Workload | 1 | 2018 | 103 | 0.040 |
Why?
|
| Data Collection | 1 | 2019 | 420 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 240 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2019 | 307 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 615 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 498 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 281 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 649 | 0.030 |
Why?
|
| Patient Safety | 1 | 2018 | 202 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 234 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 87 | 0.030 |
Why?
|
| Ceramides | 1 | 2020 | 578 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 948 | 0.030 |
Why?
|
| Morphine | 1 | 2016 | 76 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 622 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2018 | 311 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1342 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 365 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 733 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2015 | 85 | 0.030 |
Why?
|
| Depression | 1 | 2022 | 943 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2015 | 58 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1140 | 0.030 |
Why?
|
| Factor XII | 1 | 2015 | 96 | 0.030 |
Why?
|
| Catheterization | 1 | 2016 | 209 | 0.030 |
Why?
|
| Tooth | 1 | 2015 | 24 | 0.030 |
Why?
|
| Streptococcus mutans | 1 | 2015 | 11 | 0.030 |
Why?
|
| Dental Stress Analysis | 1 | 2015 | 22 | 0.030 |
Why?
|
| Molar | 1 | 2015 | 27 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 97 | 0.030 |
Why?
|
| Feedback | 1 | 2015 | 90 | 0.030 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2014 | 14 | 0.030 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2014 | 11 | 0.030 |
Why?
|
| Students, Dental | 1 | 2015 | 49 | 0.030 |
Why?
|
| Electron Transport | 1 | 2014 | 37 | 0.030 |
Why?
|
| Propensity Score | 1 | 2015 | 117 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2014 | 47 | 0.030 |
Why?
|
| Oxidants | 1 | 2014 | 48 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2016 | 205 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 72 | 0.030 |
Why?
|
| Retinoscopy | 1 | 2014 | 11 | 0.030 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 117 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1664 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 951 | 0.030 |
Why?
|
| Bradykinin | 1 | 2015 | 157 | 0.030 |
Why?
|
| Ophthalmology | 1 | 2014 | 39 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 955 | 0.030 |
Why?
|
| Biofilms | 1 | 2015 | 72 | 0.030 |
Why?
|
| Pain Management | 1 | 2016 | 186 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 243 | 0.030 |
Why?
|
| Kallikreins | 1 | 2015 | 323 | 0.030 |
Why?
|
| Surface Properties | 1 | 2015 | 363 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2016 | 193 | 0.030 |
Why?
|
| Lung | 1 | 2019 | 849 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2016 | 295 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2013 | 31 | 0.030 |
Why?
|
| Airway Management | 1 | 2013 | 20 | 0.030 |
Why?
|
| Prosthodontics | 1 | 2013 | 8 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2014 | 215 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2013 | 61 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2014 | 525 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2016 | 705 | 0.030 |
Why?
|
| Adenosine | 1 | 2013 | 165 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 1174 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2015 | 384 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2013 | 219 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2013 | 172 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 901 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2015 | 254 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 947 | 0.020 |
Why?
|
| Video Recording | 1 | 2012 | 145 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 2689 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2013 | 230 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2013 | 384 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 839 | 0.020 |
Why?
|
| Dental Anxiety | 1 | 2010 | 5 | 0.020 |
Why?
|
| Dental Prophylaxis | 1 | 2010 | 7 | 0.020 |
Why?
|
| Architectural Accessibility | 1 | 2010 | 8 | 0.020 |
Why?
|
| Coronary Stenosis | 1 | 2013 | 246 | 0.020 |
Why?
|
| Paraplegia | 1 | 2010 | 28 | 0.020 |
Why?
|
| Wheelchairs | 1 | 2010 | 16 | 0.020 |
Why?
|
| Toothbrushing | 1 | 2010 | 21 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2013 | 419 | 0.020 |
Why?
|
| Quadriplegia | 1 | 2010 | 29 | 0.020 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2010 | 73 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 1213 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 800 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 292 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 772 | 0.020 |
Why?
|
| Self Concept | 1 | 2010 | 132 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 506 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 689 | 0.020 |
Why?
|
| Patient Selection | 1 | 2013 | 592 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2010 | 186 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 508 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1426 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 931 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 450 | 0.020 |
Why?
|
| Research Design | 1 | 2012 | 729 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2009 | 249 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 807 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 596 | 0.020 |
Why?
|
| Psychometrics | 1 | 2009 | 514 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 2455 | 0.020 |
Why?
|
| Heart Failure | 1 | 2013 | 1180 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 2223 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2009 | 2800 | 0.010 |
Why?
|